Jon Cohen AIDS Research Collection

Browse Collection: Multiple Items

[Letter to Charles Carpenter from Jay Moskowitz with Agenda Attached]

Author
Moskowitz, Jay.
Publication
undated
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
letters (correspondence)

[Letter to Jon Cohen from Jon Ende with notes from the 1992 Vaccine Panel]

Access restricted by copyright holder.
Author
Ende, Jon
Publication
1992-11-24
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
letters (correspondence)

[Conference Materials, Panel to Review GP-160 Vaccine Candidate (1992: Bethesda, Maryland)]

Author
National Institutes of Health (U.S.)
Publication
1992-11-05
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
press kits

[Minutes, Advisory Committee to the Director GP-160 Meeting (1992: Bethesda, Maryland)]

Author
National Institutes of Health (U.S.)
Publication
1992-11-05
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
minutes

Panel to Review GP160 Vaccine Candidate: Report of the Meeting

Author
National Institutes of Health (U.S.)
Publication
1992-11-18
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
reports

[Minutes, Clinical Evaluation of Therapeutic Vaccines for HIV Seropositives, GP-160 Meeting (1992:Bethesda, Maryland)]

Author
National Institutes of Health (U.S.)
Publication
1992-11-23
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
minutes

[GP 160 Meeting: Presenters (1992: Bethesda, Maryland)]

Author
National Institutes of Health (U.S.)
Publication
1992-11-20
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
attendance lists

[Roster, GP 160 Meeting (1992: Bethesda, Maryland)]

Author
National Institutes of Health (U.S.)
Publication
1992-11-20
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
attendance lists

[Draft Agenda, GP160 Panel (1992: Bethesda Maryland)]

Author
National Institutes of Health (U.S.)
Publication
1992-11-20
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
agendas (administrative records)

The Potential Use of HIV Vaccines for the Treatment of HIV Infection: Scientific Summary of the State-of-the-Art

Author
National Institutes of Health (U.S.)
Publication
1992-11-23
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
reports
Back to Top Go to Pagination

Clinical Evaluation of Therapeutic Vaccines for HIV Seropositives: Approaches to the Design of Efficacy Trials

Author
National Institute of Allergy and Infectious Diseases (U.S.). Division of AIDS
Publication
1992-11-22
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
reports

[Press Packet, MicroGeneSys Biopharmaceuticals]

Author
MicroGeneSys, Inc.
Publication
MicroGeneSys, Inc.
1992
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
press kits

AIDS Vaccine Is Promising in Test Tube [The Wall Street Journal ]

Author
Bishop, Jerry E.
Publication
June 8, 1990
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
Newspaper Article

Check your library for this item

'Good News, but No Cure' [Newsweek ]

Author
Beck, Melinda, Hager, Mary, Iarovici, Doris
Publication
June 24, 1991
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
Magazine Article

Check your library for this item

Vaccine Therapy Trials Improve Immunity in HIV [U.S. Medicine volume 27, number 21 & 22]

Publication
November 1991
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
Journal Article

Check your library for this item

AIDS Vaccine May Work [The New Haven Register ]

Author
Katz, Abram
Publication
July 22, 1992
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
Newspaper Article

Check your library for this item

Vaccine Experiment Shows Virus Decline [The Hartford Courant ]

Publication
July 22, 1992
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
Newspaper Article

Check your library for this item

Unorthodox Vaccination Technique May Become Weapon in Fighting AIDS [The New York Times ]

Author
Kolata, Gina
Publication
June 13, 1991
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
Newspaper Article

Check your library for this item

New Reports of Progress on Post-AIDS Therapies [San Francisco Chronicle ]

Author
Perlman, David
Publication
July 23, 1992
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
Newspaper Article

Check your library for this item

Plans for AIDS Vaccine Trials Urged Although Drugs Remain Experimental [The Wall Street Journal ]

Author
Chase, Marilyn
Publication
July 22, 1992
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
Newspaper Article

Check your library for this item
Back to Top Go to Pagination

A Phase I Evaluation of the Safety and Immunogenicity of Vaccination with Recombinant gp160 in Patients with Early Human Immunodeficiency Virus Infection [The New England Journal of Medicine volume 324, pages 1677-1684]

Author
Redfield, Robert R., Birx, Deborah L., Ketter, Nzeera, Tramont, Edmund, Polonis, Victoria, Davis, Charles
Publication
June 13, 1991
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
Journal Article

Check your library for this item

The Safety and Immunogenicity of a Human Immunodeficiency Virus Type 1 (HIV-1) Recombinant gp160 Candidate Vaccine in Humans [Annals of Internal Medicine volume 114, number 2, pages 119-127]

Author
Dolin, Raphael, Graham, Barney S., Greenberg, Stephen B., Tacket, Carol O., Belshe, Robert B, Midthun, Karen
Publication
1991
Series/Folder Title
Government Response and Policy > Law > gp160 trials and controversy > National Institute of Health (U.S.) GP160 Meeting, Blue-Ribbon Panel (1992)
Item type:
Journal Article

Check your library for this item
Do you have questions about this content? Need to report a problem? Please contact us.